Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Children's Oncology Group
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT01503632
This randomized phase III trial studies compliance to a mercaptopurine treatment intervention
compared to standard of care in younger patients with acute lymphoblastic leukemia that has
had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing
ways to help patients who have acute lymphoblastic leukemia to take their medications as
prescribed may help them in taking their medications more consistently and may improve
treatment outcomes.
compared to standard of care in younger patients with acute lymphoblastic leukemia that has
had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing
ways to help patients who have acute lymphoblastic leukemia to take their medications as
prescribed may help them in taking their medications more consistently and may improve
treatment outcomes.
Intervention
Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Questionnaire Administration, Standard Follow-Up Care
Condition
Childhood Acute Lymphoblastic Leukemia in Remission
Investigators
Smita Bhatia